insights_auto
Why is ALKS down 2,15%?
Dive Deeperchevron_right
ALKS:NASDAQ
Alkermes Plc
42,36 $
arrow_downward
-2,15%(-0,93) 1D
23 սեպ, 10:52:26 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALKS...
Open
43,20 $
High
43,62 $
Low
42,33 $
Mkt. cap
7,11 մլրդ
Avg. vol.
1,67 մլն
Volume
290,71 հզր
P/E ratio
110,06
52-wk high
55,67 $
52-wk low
26,99 $
EPS
0,38 $
Beta
0,27
Shares outstanding
167,76 մլն
No. of employees
2 հզր
Open
43,20 $
High
43,62 $
Low
42,33 $
Mkt. cap
7,11 մլրդ
Avg. vol.
1,67 մլն
Volume
290,71 հզր
P/E ratio
110,06
52-wk high
55,67 $
52-wk low
26,99 $
EPS
0,38 $
Beta
0,27
Shares outstanding
167,76 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Yahoo Finance
·
3 ժամ առաջ
Why Alkermes (ALKS) Is Down 6.0% After First ADHD Data For Orexin Agonist ALKS 7290
Psychiatric Times
·
21 ժամ առաջ
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
Zacks
·
23 ժամ առաջ
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
Benzinga
·
1 օր առաջ
Meta To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
Profile
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
About Alkermes Plc
CEORichard F. Pops | Richard F. Pops
Employees2,05 հզր
Founded1987
Headquarters-
Sector-
Websitealkermes.com